Annapolis News Updates

Global Nerve Regeneration and Repair Market will be worth USD 11.7 billion by 2022 – New market report by Data Bridge Market Research

Global Nerve Regeneration and Repair Market will be worth USD 11.7 billion by 2022 – New market report by Data Bridge Market Research

“Global Nerve Regeneration and Repair Market is expected to grow at 11.7% in the forecast period 2016 to 2022”
Global Nerve Regeneration and Repair Market, By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User, By Geography– Trends and Forecast to 2022

Global Nerve Regeneration and Repair Market are expected to reach USD 11.7 billion by 2022, growing at a CAGR of 11.7% during the forecast period of 2016 to 2022.

Global Nerve Regeneration and Repair Market are segmented based on product type, indication, end-user and geography.

On the basis of product types the market is segmented into 2 type’s biomaterial and neurostimulation segments. The neurostimulation segment dominates the market and is further classified into internal and external neurostimulation devices. Internal neurostimulation devices is further segmented into spinal cord stimulator (SCS), deep brain stimulator (DBS), vagus nerve stimulator (VNS), sacral nerve stimulator (SNS) and gastric nerve stimulator (GNS). External neurostimulation devices market is further segmented into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS) and respiratory electrical stimulation (RES). Internal neurostimulation dominates the market owing to its greater acceptance in the clinical field and more success in pain management. The biomaterials segment is further categorized based on product types into nerve conduits, nerve protectors, nerve wraps and nerve connectors.

For Sample Report: Global Nerve Regeneration and Repair Market – Trends and Forecast to 2022

Based on indications the market is segmented into failed back surgery syndrome, conditional regional pain syndrome, eschemia, Parkinson’s disease, Alzheimer’s, urinary incontinence, faecal incontinenece, epilepsy, gastroparesis, nerve repair, nerve grafting and others. Nerve repair segment is further segmented based on repair type into epineural repair, perineural repair and group fascicular repair. Nerve grafting segment is also further segmented based on graft types into autograft, allograft and xenograft.

On the basis of End-User the market is segmented into Hospitals, Neurology Clinics, Home Healthcare, and Community Healthcare.

To read more about the scope and findings of this report visit: Global Nerve Regeneration and Repair Market to reach USD 14.6 billion

Based on geography the market covers data reports for geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market are further segmented into U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.

KEY PLAYERS OPERATING IN GLOBAL NERVE REGENERATION AND REPAIR MARKET:

  • Medtronic
  • AxoGen Inc.
  • Boston Scientific Corporation
  • Baxter International
  • Checkpoint Surgical Inc.
  • St. Jude Medical, Inc.
  • Integra Lifesciences Corporation
  • Nevro Corporation
  • Orthomed S.A.S.
  • Collagen Matrix, Inc.
  • Cyberonics, Inc.
  • Polyganics B.V.
  • Stryker Corporation

To Browse Full Report and Pricing: Global Nerve Regeneration and Repair Market – Trends and Forecast to 2022

Table of Content:

1              INTRODUCTION

1.1.         OVERVIEW OF THE NERVE REGENERATION AND REPAIR MARKET

1.2.         MARKET SEGMENTATION & COVERAGE

1.2.1.     CURRENCY AND PRICING 

1.2.2.     LIMITATION

1.2.3.     STAKEHOLDERS

2              RESEARCH METHODOLOGY

2.1.         KEY TAKEAWAYS

2.2.         ARRIVING AT THE GLOBAL NERVE REGENERATION AND REPAIR MARKET SIZE

2.2.1.     MARKET CRACKDOWN APPROACH 

2.2.2.     COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.     DATA TRIANGULATION

2.2.4.     KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.     KEY DATA POINTS FROM SECONDARY SOURCES

2.2.6.     PORTER’S FIVE FORCES MATRIX

2.4.         GLOBAL NERVE REGENERATION AND REPAIR MARKET: RESEARCH SNAPSHOT

2.5.         ASSUMPTIONS

3              MARKET LANDSCAPE SUMMARY

4              PREMIUM INSIGHTS

4.1.         OVERVIEW

4.2.         GLOBAL NERVE REGENERATION AND REPAIR MARKET: KEY PRIMARY INSIGHTS

4.3.         MARKET OVERVIEW

4.3.1.     DRIVERS

                4.3.1.1.   INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES

                4.3.1.2.   TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR

                4.3.1.3.   FAVORABLE REIMBURSEMENT POLICIES

                4.3.1.4.   EXPANDED TARGET APPLICATIONS

4.3.2.     RESTRAINTS

                4.3.2.1.   LACK OF PATIENT AWARENESS

                4.3.2.2.   LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS

4.3.3.     OPPURTUNITIES

                4.3.3.1.   NOVEL THERAPIES SUCH AS STEM CELL THERAPY

                4.3.3.2.   RISING ACCEPTANCE OF EMERGING MARKETS

4.3.4.     THREATS

                4.3.4.1.   DONOR SITE MORBIDITY

                4.3.4.2.   INADEQUATE NERVE REGENERATION BY CONDUITS

4.4.         KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5              NERVE REGENERATION AND REPAIR MARKET, BY TYPE

5.1.         OVERVIEW

5.2.         BIOMATERIALS

5.2.1.     NERVE CONDUITS

5.2.2.     NERVE PROTECTORS

5.2.3.     NERVE WRAPS

5.2.4.     NERVE CONNECTORS

5.3.         NEUROSTIMALATION

5.3.1.     INTERNAL NEUROSTIMULATION

                5.3.1.1.   SPINAL CORD STIMULATOR

                5.3.1.2.   DEEP BRAIN STIMULATOR

                5.3.1.3.   VAGUS NERVE STIMULATOR

                5.3.1.4.   SACRAL NERVE STIMULATOR

                5.3.1.5.   GASTRIC NERVE STIMULATOR

5.3.2.     EXTERNAL NEUROSTIMULATION

                5.3.2.1.   TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)

                5.3.2.2.   TRANSCRANIAL MAGNETIC STIMULATION (TMS)

                5.3.2.3.   RESPIRATORY ELECTRICAL STIMULATION (RES)

6              NERVE REGENERATION AND REPAIR MARKET, BY INDICATION

6.1.         OVERVIEW

6.2.         FAILED BACK SURGERY SYNDROME

6.3.         PARKINSON’S DISEASE

6.4.         URINARY INCONTINENCE

6.5.         EPILEPSY

6.6.         GASTROPARESIS

6.7.         NERVE REPAIR

6.7.1.     EPINEURAL NERVE REPAIR

6.7.2.     PERINEURAL NERVE REPAIR

6.7.3.     GROUP FASCICULAR REPAIR

6.8.         GRAFTING

6.8.1.     ALLOGRAFT

6.8.2.     XENOGRAFT

7              NERVE REGENERATION AND REPAIR MARKET, BY END USER

7.1.         OVERVIEW

7.2.         HOSPITALS

7.3.         NEUROLOGY CLINICS

7.4.         HOME CARE SETTINGS

7.5.         OTHERS

8              NERVE REGENERATION AND REPAIR MARKET, BY GEOGRAPHY

8.1.         COUNTRYWISE NERVE REGENERATION AND REPAIR MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                8.1.1.      NORTH AMERICA

                              8.1.1.1.      U.S.

                              8.1.1.2.      CANADA

                              8.1.1.3.      MEXICO

                8.1.2.      EUROPE

                              8.1.2.1.      GERMANY

                              8.1.2.2.      FRANCE

                              8.1.2.3.      U.K.

                              8.1.2.4.      ITALY

                              8.1.2.5.      SPAIN

                              8.1.2.6.      RUSSIA

                              8.1.2.7.      TURKEY

                              8.1.2.8.      BELGIUM

                              8.1.2.9.      NETHERLANDS

                              8.1.2.10.      SWITZERLAND

                              8.1.2.11.    REST OF EUROPE

                8.1.3.      ASIA-PACIFIC (APAC)

                              8.1.3.1.      JAPAN

                              8.1.3.2.      CHINA

                              8.1.3.3.      SOUTH KOREA

                              8.1.3.4.      INDIA

                              8.1.3.5.      AUSTRALIA

                              8.1.3.6.      SINGAPORE

                              8.1.3.7.      THAILAND

                              8.1.3.8.      MALAYSIA

                              8.1.3.9.      INDONESIA

                              8.1.3.10.      PHILIPPINES

                              8.1.3.11.      REST OF APAC

                8.1.4.    LATIN AMERICA

                              8.1.4.1.     BRAZIL

                              8.1.4.2.     REST OF LATIN AMERICA

                8.1.5.    MIDDLE EAST AND AFRICA

                              8.1.5.1.     SOUTH AFRICA

                              8.1.5.2.     REST OF MIDDLE EAST AND AFRICA

8.2.         KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

9              NERVE REGENERATION AND REPAIR MARKET: COMPETITIVE LANDSCAPE

9.1.         GLOBAL NERVE REGENERATION AND REPAIR MARKET: COMPANY SHARE ANALYSIS

9.2.         U.S. NERVE REGENERATION AND REPAIR MARKET: COMPANY SHARE ANALYSIS

9.3.         EUROPE NERVE REGENERATION AND REPAIR MARKET: COMPANY SHARE ANALYSIS

9.4.         APAC NERVE REGENERATION AND REPAIR MARKET: COMPANY SHARE ANALYSIS

9.5.         SOUTH AMERICA NERVE REGENERATION AND REPAIR MARKET: COMPANY SHARE ANALYSIS

9.6.         MIDDLE EAST AND AFRICA  NERVE REGENERATION AND REPAIR MARKET: COMPANY SHARE ANALYSIS

9.7.         MERGERS & ACQUISITIONS

9.8.         NEW PRODUCT DEVELOPMENT & APPROVALS

9.9.         EXPANSIONS

9.10.      REGULATORY CHANGES

9.11.      PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

10           NERVE REGENERATION AND REPAIR MARKET, COMPANY PROFILES

10.1        MEDTRONIC

                                 10.1.1   OVERVIEW

                                 10.1.2   SWOT ANALYSIS

                                 10.1.3   PRODUCT PORTFOLIO

                                 10.1.4   REVENUE ANALYSIS

                                 10.1.5   ANALYSTS VIEW

10.2        AXOGEN INC.

                                 10.2.1   OVERVIEW

                                 10.2.2   SWOT ANALYSIS

                                 10.2.3   PRODUCT PORTFOLIO

                                 10.2.4   REVENUE ANALYSIS

                                 10.2.5   ANALYSTS VIEW

10.3        BOSTON SCIENTIFIC CORPORATION

                                 10.3.1   OVERVIEW

                                 10.3.2   SWOT ANALYSIS

                                 10.3.3   PRODUCT PORTFOLIO

                                 10.3.4   REVENUE ANALYSIS

                                 10.3.5   ANALYST VIEW

10.4        BAXTER INTERNATIONAL

                                 10.4.1   OVERVIEW

                                 10.4.2   SWOT ANALYSIS

                                 10.4.3   PRODUCT PORTFOLIO

                                 10.4.4   REVENUE ANALYSIS

                                 10.4.5   ANALYSTS VIEW

10.5        CHECKPOINT SURGICAL INC.

                                 10.5.1   OVERVIEW

                                 10.5.2   SWOT ANALYSIS

                                 10.5.3   PRODUCT PORTFOLIO

                                 10.5.4   REVENUE ANALYSIS

                                 10.5.5   ANALYSTS VIEW

10.6        ST. JUDE MEDICAL, INC.

                                 10.6.1   OVERVIEW

                                 10.6.2   SWOT ANALYSIS

                                 10.6.3   PRODUCT PORTFOLIO

                                 10.6.4   REVENUE ANALYSIS

                                 10.6.5   ANALYSTS VIEW

10.7        INTEGRA LIFESCIENCES CORPORATION

                                 10.7.1   OVERVIEW

                                 10.7.2   SWOT ANALYSIS

                                 10.7.3   PRODUCT PORTFOLIO

                                 10.7.4   REVENUE ANALYSIS

                                 10.7.5   ANALYSTS VIEW

10.8        NEVRO CORPORATION

                                 10.8.1   OVERVIEW

                                 10.8.2   SWOT ANALYSIS

                                 10.8.3   PRODUCT PORTFOLIO

                                 10.8.4   REVENUE ANALYSIS

                                 10.1.5   ANALYSTS VIEW

 

 

10.9        ORTHOMED S.A.S.

                                 10.9.1   OVERVIEW

                                 10.9.2   SWOT ANALYSIS

                                 10.9.3   PRODUCT PORTFOLIO

                                 10.9.4   REVENUE ANALYSIS

                                 10.9.5   ANALYSTS VIEW

10.10     COLLAGEN MATRIX, INC.

                                 10.10.1   OVERVIEW

                                 10.10.2   SWOT ANALYSIS

                                 10.10.3   PRODUCT PORTFOLIO

                                 10.10.4   REVENUE ANALYSIS

                                 10.10.5   ANALYSTS VIEW

10.11     CYBERONICS, INC.

                                 10.11.1   OVERVIEW

                                 10.11.2   SWOT ANALYSIS

                                 10.11.3   PRODUCT PORTFOLIO

                                 10.11.4   REVENUE ANALYSIS

                                 10.11.5   ANALYSTS VIEW

10.12     POLYGANICS B.V.

                                 10.12.1   OVERVIEW

                                 10.12.2   SWOT ANALYSIS

                                 10.12.3   PRODUCT PORTFOLIO

                                 10.12.4   REVENUE ANALYSIS

                                 10.12.5   ANALYSTS VIEW

10.13     STRYKER CORPORATION

                                 10.13.1   OVERVIEW

                                 10.13.2   SWOT ANALYSIS

                                 10.13.3   PRODUCT PORTFOLIO

                                 10.13.4   REVENUE ANALYSIS

                                 10.13.5   ANALYSTS VIEW

11           APPENDIX

12           ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Asia Pacific (APAC) Nerve Regeneration and Repair Market – Trends and Forecast to 2022

By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User (Hospitals, Neurology Clinics, Home Healthcare, Community Healthcare), By Country (China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Taiwan, Indonesia, Australia, Rest of APAC) – Trends and Forecast to 2022

North America Nerve Regenaration and Repair Market – Trends and Forecast to 2022

By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User (Hospitals, Neurology Clinics, Home Healthcare, Community Healthcare), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2022

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-nerve-repair-and-regeneration-market/

Calendar

November 2017
M T W T F S S
« Oct    
 12345
6789101112
13141516171819
20212223242526
27282930